Newron Pharmaceuticals Supports Rare Disease Day And Joins Global Movement To Raise Awareness For Rare Diseases

MILAN--(BUSINESS WIRE)--Newron Pharmaceuticals S.p.A. (“Newron”), a biopharmaceutical company focused on the development of novel therapies for patients with diseases of the central nervous system (CNS) and pain, today announced it has joined forces with 300 million people living with rare diseases and health care advocates around the world for Rare Disease Day®, an annual global initiative dedicated to elevating public understanding of rare diseases and calling attention to the special challenges of people affected by these.